[en] Cerebral amyloid angiopathy-related inflammation (CAA-ri) is a rare autoimmune encephalopathy of aging caused by an autoantibody immune response against Aβ protein deposited in the brain of older adults affected by cerebral amyloid angiopathy (CAA) and Alzheimer's disease pathology. Its most common clinical manifestations are (sub)acute-onset cognitive and behavioral abnormalities, focal deficits, seizures, and headaches. Brain magnetic resonance imaging shows characteristic extensive and confluent white matter hyperintensities and CAA features. The response to immunosuppressive treatment is generally good. Here, we report the case of a 62-year-old patient with CAA-ri confirmed on biopsy, who had previously repeatedly received chemotherapy for multiple cancers. We summarize his clinical data, neuroradiological features, and therapeutic response and comment on the potential mechanisms connecting multiple cancers and chemotherapies with CAA-ri.
Disciplines :
Neurology Oncology
Author, co-author :
Severijns, Christophe ; Centre Hospitalier Universitaire de Liège - CHU > > Service de neurologie
Drion, Emilie ; Centre Hospitalier Universitaire de Liège - CHU > > Service de neurologie
Bianchi, Elettra ; Centre Hospitalier Universitaire de Liège - CHU > > Service d'anatomie et cytologie pathologiques
Maquet, Pierre ; Centre Hospitalier Universitaire de Liège - CHU > > Service de neurologie
Language :
English
Title :
Cerebral Amyloid Angiopathy-Related Inflammation following Multiple Cancers and Chemotherapies.
Charidimou A, Gang Q, Werring DJ. Sporadic cerebral amyloid angiopathy revisited: recent insights into pathophysiology and clinical spectrum. J Neurol Neurosurg Psychiatry. 2012 Feb; 83 (2): 124-37. http://dx.doi.org/10.1136/jnnp-2011-301308.
Antolini L, DiFrancesco JC, Zedde M, Basso G, Arighi A, Shima A,. Spontaneous ARIA-like events in cerebral amyloid angiopathy: related inflammation. Neurology. 2021 Nov 2; 97 (18): e1809-22.
Auriel E, Charidimou A, Edip Gurol M, Ni J, Van Etten ES, Martinez-Ramirez S,. Validation of clinicoradiological criteria for the diagnosis of cerebral amyloid angiopathy-related inflammation. JAMA Neurol. 2016; 73 (2): 197-202.
Moussaddy A, Levy A, Strbian D, Sundararajan S, Berthelet F, Lanthier S. Inflammatory cerebral amyloid angiopathy, amyloid-β-related angiitis, and primary angiitis of the central nervous system: similarities and differences. Stroke. 2015 Sep; 46 (9): e210-3.
Corovic A, Kelly S, Markus HS. Cerebral amyloid angiopathy associated with inflammation: a systematic review of clinical and imaging features and outcome. Int J Stroke. 2018; 13 (3): 257-67. http://dx.doi.org/10.1177/1747493017741569.
Piazza F, Greenberg SM, Savoiardo M, Gardinetti M, Chiapparini L, Raicher I,. Anti-amyloid β autoantibodies in cerebral amyloid angiopathy-related inflammation: implications for amyloid-modifying therapies. Ann Neurol. 2013 Apr; 73 (4): 449-58.
Chwalisz BK. Cerebral amyloid angiopathy and related inflammatory disorders. J Neurol Sci. 2021; 424: 117425. http://dx.doi.org/10.1016/j.jns.2021.117425.
Eng JA, Frosch MP, Choi K, Rebeck GW, Greenberg SM. Clinical manifestations of cerebral amyloid angiopathy-related inflammation. Ann Neurol. 2004; 55 (2): 250-6. http://dx.doi.org/10.1002/ana.10810.
Femia G, Hardy TA, Spies JM, Horvath LG. Posterior reversible encephalopathy syndrome following chemotherapy with oxaliplatin and a fluoropyrimidine: a case report and literature review. Asia Pac J Clin Oncol. 2012 Jun; 8 (2): 115-22. http://dx.doi.org/10.1111/j.1743-7563.2012.01544.x.
Koudriavtseva T, Lorenzano S, Anelli V, Sergi D, Stefanile A, Di Domenico EG,. Case report: probable cerebral amyloid angiopathy-related inflammation during bevacizumab treatment for metastatic cervical cancer. Front Oncol. 2021 Jul 27; 11.
Lasocki A, Kee D. Clinical and radiological evolution of cerebral amyloid angiopathy-related inflammation in the context of anti-PD-1 immunotherapy. Melanoma Res. 2020; 30 (6): 608-12. http://dx.doi.org/10.1097/CMR.0000000000000683.
Marini A, Bernardini A, Gigli GL, Valente M, Muñiz-Castrillo S, Honnorat J,. Neurologic adverse events of immune checkpoint inhibitors. Neurology. 2021 Apr 20; 96 (16): 754-66.
Nelson T, Leung B, Bannykh S, Shah KS, Patel J, Dumitrascu OM. Cerebral amyloid angiopathy-related inflammation in the immunosuppressed: a case report. Front Neurol. 2019; 10: 1283. http://dx.doi.org/10.3389/fneur.2019.01283.
Zwang NA, Turka LA. Homeostatic expansion as a barrier to lymphocyte depletion strategies. Curr Opin Organ Transplant. 2014 Aug; 19 (4): 357-62. http://dx.doi.org/10.1097/MOT.0000000000000096.
